PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218 | -33.5% | 70,583 | -3.1% | 0.02% | -42.4% |
| Q2 2023 | $328 | +21.0% | 72,834 | +53.0% | 0.03% | +22.2% |
| Q1 2023 | $271 | -6.2% | 47,614 | -0.4% | 0.03% | -25.0% |
| Q4 2022 | $289 | -99.9% | 47,801 | -11.8% | 0.04% | -23.4% |
| Q3 2022 | $358,000 | +87.4% | 54,173 | +47.9% | 0.05% | +62.1% |
| Q2 2022 | $191,000 | +19.4% | 36,626 | +57.9% | 0.03% | +38.1% |
| Q1 2022 | $160,000 | – | 23,201 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $124,994,000 | 1.61% |
| Baker Brothers Advisors | 10,123,824 | $126,042,000 | 0.61% |
| Pinz Capital Management, LP | 43,800 | $545,000 | 0.21% |
| HHLR ADVISORS, LTD. | 583,333 | $7,262,000 | 0.11% |
| Rock Springs Capital Management LP | 368,959 | $4,594,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 20,350 | $253,000 | 0.08% |
| Virtus ETF Advisers LLC | 13,815 | $172,000 | 0.06% |
| PDT Partners, LLC | 35,907 | $447,000 | 0.03% |
| Jump Financial, LLC | 36,900 | $459,000 | 0.03% |
| Parkwood LLC | 12,667 | $158,000 | 0.03% |